Kaneka Corporation

4118

JP3215800008

Commodity Chemicals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
3,990 ^JPY	+1.40%		+2.57%	+11.39%

Apr. 22	Sony Corporation Adopts Kaneka Corporation's Foam Molded Product Made from Kaneka Biodegradable Polymer Green Planet as A Cushioning Material for Its Large-Screen Televisions	CI
Apr. 01	Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024.	CI

Kaneka Corporation acquired Japan Medical Device Technology Co., Ltd.

November 29, 2023

Kaneka Corporation (TSE:4118) acquired Japan Medical Device Technology Co., Ltd on November 30, 2023.

Kaneka Corporation (TSE:4118) completed the acquisition of Japan Medical Device Technology Co., Ltd on November 30, 2023.

Latest news about Kaneka Corporation

Sony Corporation Adopts Kaneka Corporation's Foam Molded Product Made from Kaneka Biodegradable Polymer Green Planet as A Cushioning Material for Its Large-Screen Televisions	Apr. 22	CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024.	Apr. 01	CI
Kaneka Corporation announces an Equity Buyback for 2,000,000 shares, representing 3.08% for ¥8,000 million.	Feb. 08	CI
Kaneka Corporation authorizes a Buyback Plan.	Feb. 07	CI
Kaneka Corporation acquired Japan Medical Device Technology Co., Ltd.	Nov. 29	CI
Sun-Novo Pharma Gets License to Produce Kaneka’s Transdermal Patches	23-05-16	MT
Kaneka Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on September 9, 2022.	23-03-21	CI
Kaneka Corporation's Equity Buyback announced on September 9, 2022 has closed with 2,300,000 shares, representing 3.47% for ¥8,042.21 million.	23-03-19	CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on September 9, 2022.	23-01-03	CI
Kaneka Corporation Announces Manufacture and Supply Intermediates to Shionogi & Co., Ltd for Use in Xocova®	22-11-29	CI
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on September 9, 2022.	22-09-30	CI
Kaneka Corporation announces an Equity Buyback for 2,300,000 shares, representing 3.42% for ¥10,000 million.	22-09-09	CI
Kaneka Corporation authorizes a Buyback Plan.	22-09-08	CI
Kaneka Corporation agreed to acquire remaining 45.24% stake in Cemedine Co., Ltd..	22-05-11	CI
Kaneka Launches New PCR Test Kit for Identifying the COVID-19 Omicron (BA.1) and "Stealth" Omicron (BA.2) Variants	22-04-13	CI
Kaneka Corporation to Significantly Increase Its Production Capacity for Kaneka Biodegradable Polymer Green Planet™ in Japan	22-02-06	CI
Banners, lights as Japan hails MVP award for baseballer Ohtani	21-11-19	RE
Kaneka Releases PCR Test Kit for COVID-19 Variants	21-10-10	CI
Kaneka : Inovio signs COVID-19 vaccine manufacturing deal with Japan's Kaneka	20-12-03	RE
Denka : Japan to extend foreign investment controls to Avigan suppliers - Yomiuri	20-05-10	RE
Kaneka Corporation Agrees to Supply Active Pharmaceutical Ingredients for Avigan Tablet	20-04-16	CI
Kaneka Corporation Announces Consolidated Financial Results for the Nine Months Ended December 31, 2019; Provides Consolidated Financial Guidance for the Year Ending March 31, 2020	20-02-11	CI
Kaneka Corporation(TSE:4118) dropped from S&P Japan Mid Cap 100	19-12-23	CI
Kaneka Corporation Reports Consolidated Earnings Results for the Year Ended March 31, 2019	19-11-11	CI

Chart Kaneka Corporation

Duration

Period

More charts

Company Profile

KANEKA CORPORATION is a Japan-based company engaged in four business segments. The Material Solutions Unit segment includes general purpose vinyl chloride resin, caustic soda, polyvinyl chloride special resin, modifier, modified silicone polymer, biodegradable polymer. Quality of Life Solutions Unit segment includes expanded styrene resin and molded products, extruded polystyrene foam boards, bead method expanded polyolefin, solar circuit method, super heat resistant polyimide films, optical materials, super heat conductive graphite sheets, solar cells, storage batteries for housing and others. The Health Care Solutions Unit segment includes medical devices, low molecular weight pharmaceutical raw materials, biopharmaceuticals, etc. The Nutrition Solutions Unit segment includes functional food ingredients, margarine, shortening, baker's yeast, spices, antifreeze ingredients, functional fertilizers and feeds.

Sector

Commodity Chemicals

Calendar

2024-05-13 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Kaneka Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

3,990 JPY

Average target price

4,091 JPY

Spread / Average Target

+2.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Commodity Chemicals

	1st Jan change	Capi.
KANEKA CORPORATION	+11.39%	1.64B
AIR LIQUIDE	+5.14%	103B
SAUDI BASIC INDUSTRIES CORPORATION	-5.63%	63.04B
PT CHANDRA ASRI PACIFIC TBK	+39.52%	39.06B
WANHUA CHEMICAL GROUP CO., LTD.	+12.91%	37.58B
LYONDELLBASELL INDUSTRIES N.V.	+7.41%	33.26B
WESTLAKE CORPORATION	+6.85%	19.22B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+12.86%	16.83B
RONGSHENG PETROCHEMICAL CO., LTD.	+7.73%	15.03B
HENGLI PETROCHEMICAL CO.,LTD.	+16.93%	14.96B

Other Commodity Chemicals